Skip to main content
1-featuredimage

Welcome to hubXchange's Oligonucleotide & Peptides Xchange Europe 2025.

This event brings together senior-level scientists and executives from the pharmaceutical and biotech sectors to tackle key challenges in New Modalities, Drug Discovery, Drug Delivery, and CMC & Process Development.

Attendees can engage in roundtable discussions, pre-booked 1:1 meetingspresentations, and networking sessions with top industry experts, to foster collaboration and find innovative solutions to accelerate Oligonucleotides.

Take advantage of this unique highly interactive meeting format designed for maximum engagement, collaboration, and networking.

Munich | Tuesday 2nd December 2025 | 08:00am - 05:45pm

VIEW AGENDA    REGISTER FOR FREE   OUR PARTNERS    EVENT INFORMATION

Why choose hubXchange?

FULL AGENDA

Click the topic titles to find out more!

Loading
08:00
  1. Registration
    30 mins
    • New Modalities
    • Drug Discovery
    • Drug Delivery
    • CMC & Process Development
08:30
  1. Opening Address & Keynote Presentation: Nucleic acid conjugates: from supramolecular systems to therapeutic applications
    30 mins
    • New Modalities
    • Drug Discovery
    • Drug Delivery
    • CMC & Process Development
    Amphiphilic biomolecules are emerging as promising supramolecular materials for biomedical and technological applications. In this presentation we will highlight the recent progresses in the field of ...
09:05
  1. Drug Discovery
    60 mins
    • Drug Discovery
    Improving the efficiency of oligonucleotide synthesis and purification to ensure consistent access to high-quality materials for early discovery programs. Approaches to evaluate drug metabolism and ph ...
  2. Drug Delivery
    60 mins
    • Drug Delivery
    Enhancing efficacy and stability with novel oligonucleotide modifications and chemistries Beyond target mRNA KD: Diversifying oligo modalities and Mode of Actions Leveraging d AI/machine learning for ...
  3. CMC & Process Development
    60 mins
    • CMC & Process Development
    Defining acceptance criteria Over-designed oligonucleotide drugs - hurdles in upscaling and GMP analytics Expectations in scalability, quality, budget and time lines - finding an adequate CDMO Impact ...
10:10
  1. 1-2-1 Meetings/Networking Break
    30 mins
    • New Modalities
    • Drug Discovery
    • Drug Delivery
    • CMC & Process Development
10:40
  1. 1-2-1 Meetings/Networking Break
    30 mins
    • New Modalities
    • Drug Discovery
    • Drug Delivery
    • CMC & Process Development
11:10
  1. Morning Refreshments
    10 mins
    • New Modalities
    • Drug Discovery
    • Drug Delivery
    • CMC & Process Development
11:20
  1. Drug Discovery
    60 mins
    • Drug Discovery
  2. CMC & Process Development
    60 mins
    • CMC & Process Development

    ChemGenes

12:20
  1. Networking Lunch
    60 mins
    • New Modalities
    • Drug Discovery
    • Drug Delivery
    • CMC & Process Development
13:25
  1. Spotlight Presentation: CMC Framework for Oligonucleotide Development
    30 mins
    • New Modalities
    • Drug Discovery
    • Drug Delivery
    • CMC & Process Development
    Definition of CMC framework for therapeutic oligonucleotides. Phase-appropriate overview of the CMC framework, spanning from IND-enabling studies to commercialization. Practical roadmap for navigating ...
14:00
  1. 1-2-1 Meetings/Networking Break
    30 mins
    • New Modalities
    • Drug Discovery
    • Drug Delivery
    • CMC & Process Development
14:30
  1. 1-2-1 Meetings/Networking Break
    30 mins
    • New Modalities
    • Drug Discovery
    • Drug Delivery
    • CMC & Process Development
15:00
  1. Afternoon Refreshments
    10 mins
    • New Modalities
    • Drug Discovery
    • Drug Delivery
    • CMC & Process Development
15:10
  1. CMC & Process Development
    Spotlight Presentation: ALE RNA Chemistry
    30 mins
    • CMC & Process Development
15:45
  1. New Modalities
    60 mins
    • New Modalities
  2. Drug Delivery
    60 mins
    • Drug Delivery
    Discussion Points:   1. Strategies for Enhancing Targeted Delivery with Next-Generation LNPs What advances in lipid composition, particle engineering, or surface modification are most promising for ce ...
  3. CMC & Process Development
    60 mins
    • CMC & Process Development
    Optimizing delivery systems for RNA therapeutics to improve targeting, uptake, and bioavailability in diverse tissues Exploring RNA therapeutics in clinical and preventive applications with respirator ...
16:45
  1. Evening Drinks Reception
    60 mins
    • New Modalities
    • Drug Discovery
    • Drug Delivery
    • CMC & Process Development

 

EVENT INFORMATION

3-featuredimage

DATES

Europe
Dec 2, 2025

Tuesday 2nd December 2025

 

DoubleTree by Hilton San Francisco Airport Hotel Photo

VENUE

Hilton Munich Airport Hotel

Terminalstraße Mitte 20
85356 München-Flughafen
Germany

MAP

4-featuredimage

EVENT PARTNERS

REGISTRATION FORM

5-featuredimage

Complimentary Registration is only available for Senior Scientists & above, in Pharma & Bio Tech, with an active drug pipeline.
 

For Service Providers, please click here.